Skip to main content
Matty Rypto Photo
Mahathir Bayena

Mahathir Bayena

GrafaCrypto Journalist

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.

Articles by Mahathir Bayena

Grafa

Gilead Sciences gains EU approval for Trodelvy in first-line metastatic TNBC

Gilead Sciences (NASDAQ:GILD) announced that the European Commission has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for adult patients with unresectable or metastatic triple-negative breast cancer who have not received prior systemic therapy and are not candidates for PD-1 or PD-L1 inhibitor treatment.

Read more: Gilead Sciences gains EU approval for Trodelvy in first-line metastatic TNBC